Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Using FAPI PET-CT to diagnose endometriosis

Official title: Use of Fibroblast Activation Protein Inhibitor (FAPI) PET-CT Before Surgery in Patient with Endometriosis

Run by Ziv Hospital · NCT06792318 · Data updated 2026-11-12

This study is testing a new imaging method called FAPI PET-CT to see if it can help diagnose endometriosis in patients before they have surgery.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment30 (estimated)
SponsorZiv Hospital
Government
Drugs / interventionsRadiation
Locations1 site (Safed)
StatusRecruiting
StartedMarch 2025
Main results expectedJanuary 2027
Study endsJune 2027
Registry record updatedJanuary 24, 2025
Trial IDNCT06792318 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are females aged 18-45 with clinical suspicion of endometriosis who are scheduled for laparoscopic surgery.

Probably not a fit

Patients who are pregnant, breastfeeding, or have a history of pelvic radiation therapy or active malignancy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility of FAPI PET-CT imaging for diagnosing endometriosis in patients scheduled for surgery. Participants will receive a single injection of FAPI and undergo multiple imaging sessions to assess the presence of endometriotic lesions. The results from the imaging will be compared with surgical findings and pathology to determine accuracy. The study aims to provide a non-invasive method for better pre-operative planning and lesion mapping.

Why it matters

Potential benefit: If successful, this approach could lead to more accurate and less invasive diagnosis of endometriosis, improving patient outcomes.

How similar studies have gone: While the use of FAPI PET-CT is a novel approach in this context, similar imaging techniques have shown promise in other diagnostic applications.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female participants aged 18-45 years
* Clinical suspicion of endometriosis based on symptoms
* Scheduled for diagnostic/therapeutic laparoscopic surgery
* Ability to understand and provide written informed consent
* Completed and signed Radiation Exposure Documentation Form

Exclusion Criteria:

* Pregnant women or women who are breastfeeding
* History of pelvic radiation therapy
* Known active malignancy
* Exposure to ionizing radiation for medical purposes within 12 months prior to enrollment

Where it's running

  • Ziv Medical Center
    Safed, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.